The cellular immunodeficiency associated with post-traumatic stress disorder may be the result of sympathetic overactivity and be correctable by beta-2-blockers.
Namazi
M R
MR
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D001342:Autonomic Nervous System Diseases / Q000188:drug therapy* / Q000209:etiology / Q000276:immunology*; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects / Q000276:immunology; D016867:Immunocompromised Host / Q000187:drug effects / Q000502:physiology; D040921:Stress Disorders, Traumatic / Q000150:complications / Q000276:immunology*
D000319:Adrenergic beta-Antagonists